- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/14 - Particulate form, e.g. powders
Patent holdings for IPC class A61K 9/14
Total number of patents in this class: 10164
10-year publication summary
770
|
748
|
843
|
741
|
824
|
751
|
665
|
564
|
515
|
141
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
103 |
Board of Regents, The University of Texas System | 5370 |
67 |
Massachusetts Institute of Technology | 9795 |
54 |
Chiesi Farmaceutici S.p.A. | 940 |
52 |
Crititech, Inc. | 76 |
46 |
MannKind Corporation | 531 |
44 |
Novartis AG | 11238 |
42 |
Mayo Foundation for Medical Education and Research | 2981 |
41 |
Merck Patent GmbH | 5909 |
38 |
Elan Pharma International Limited | 73 |
37 |
Pfizer Inc. | 3322 |
36 |
Modernatx, Inc. | 1181 |
35 |
The University of North Carolina at Chapel Hill | 1928 |
35 |
The Johns Hopkins University | 5377 |
32 |
BASF SE | 19740 |
31 |
Takeda Pharmaceutical Company Limited | 2961 |
31 |
Abraxis BioScience, LLC | 213 |
30 |
The General Hospital Corporation | 4517 |
28 |
Northwestern University | 3112 |
28 |
Allergan, Inc. | 2600 |
26 |
Other owners | 9328 |